Procter & Gamble (PG)
(Delayed Data from NYSE)
$166.85 USD
+0.81 (0.49%)
Updated May 10, 2024 04:00 PM ET
After-Market: $166.85 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth B Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$166.85 USD
+0.81 (0.49%)
Updated May 10, 2024 04:00 PM ET
After-Market: $166.85 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth B Momentum D VGM
Zacks News
The Zacks Analyst Blog Highlights Stocks recently featured in the blog include: The Procter & Gamble, Verizon Communications, Intuitive Surgical, Norfolk Southern and The Allstate
by Zacks Equity Research
The Procter & Gamble, Verizon Communications, Intuitive Surgical, Norfolk Southern and The Allstate are included in this Analyst Blog.
Top Research Reports for Procter & Gamble, Verizon & Intuitive Surgical
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including The Procter & Gamble Company (PG), Verizon Communications Inc. (VZ) and Intuitive Surgical, Inc. (ISRG).
New to Investing? This 1 Consumer Staples Stock Could Be the Perfect Starting Point
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.
Procter & Gamble Company (The) (PG) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
P&G (PG) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Has Altria Group (MO) Outpaced Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Here is how Altria (MO) and Procter & Gamble (PG) have performed compared to their sector so far this year.
P&G (PG) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), P&G (PG) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
How to Boost Your Portfolio with Top Consumer Staples Stocks Set to Beat Earnings
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Procter & Gamble Company (The) (PG) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
P&G (PG) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Company News for Apr 22, 2024
by Zacks Equity Research
Companies in The News Are: PG,AXP,RFFITB
Should You Invest in the Consumer Staples Select Sector SPDR ETF (XLP)?
by Zacks Equity Research
Sector ETF report for XLP
Key Insights from Corporate Earnings
by Zacks Equity Research
Key Insights from Corporate Earnings
Procter & Gamble (PG) Q3 Earnings Top Estimates, Sales Miss
by Zacks Equity Research
Procter & Gamble's (PG) Q3 results gain from sales growth across operating segments, improved organic sales and margin expansion, offset by higher SG&A expenses.
Pre-Markets Point to a Lower Week; P&G, AmEx, Fifth Third Beat
by Mark Vickery
Market indices have stemmed the tide from triple-digit losses early this morning, but are still in the red.
P&G (PG) Reports Q3 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
While the top- and bottom-line numbers for P&G (PG) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Procter & Gamble (PG) Q3 Earnings Beat Estimates
by Zacks Equity Research
P&G (PG) delivered earnings and revenue surprises of 7.04% and 1.41%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Markets Mixed as Q1 Earnings, Powell Control News Headlines
by Mark Vickery
Wednesday morning brings us more Q1 earnings reports, including from Abbott Labs (ABT) and U.S. Bancorp (USB).
Unlocking Q3 Potential of P&G (PG): Exploring Wall Street Estimates for Key Metrics
by Zacks Equity Research
Besides Wall Street's top -and-bottom-line estimates for P&G (PG), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2024.
Will Strategies Help Procter & Gamble (PG) Beat on Q3 Earnings?
by Zacks Equity Research
Procter & Gamble (PG) is progressing well with its pricing actions, business investments, and productivity and cost-saving plans. These are likely to have supported its Q3 performance.
Procter & Gamble (PG) Stock Moves -0.33%: What You Should Know
by Zacks Equity Research
Procter & Gamble (PG) closed at $155.33 in the latest trading session, marking a -0.33% move from the prior day.
Procter & Gamble (PG) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
P&G (PG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Procter & Gamble (PG) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Procter & Gamble (PG) closed at $155.84, marking a -0.89% move from the previous day.
Will P&G (PG) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
P&G (PG) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Wall Street Analysts See P&G (PG) as a Buy: Should You Invest?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), P&G (PG) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Here is What to Know Beyond Why Procter & Gamble Company (The) (PG) is a Trending Stock
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to P&G (PG). This makes it worthwhile to examine what the stock has in store.
Procter & Gamble (PG) Increases Yet Falls Behind Market: What Investors Need to Know
by Zacks Equity Research
In the closing of the recent trading day, Procter & Gamble (PG) stood at $156.10, denoting a +0.42% change from the preceding trading day.